TIVITY HEALTH, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Cash flows from operating activities:
Income (loss) from continuing operations
Loss from discontinued operations
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss on extinguishment of debt
Depreciation and amortization
Amortization and write-off of deferred loan costs
Amortization and write-off of debt discount
Share-based employee compensation expense
Loss on sale of MeYou Health
(Gain) loss on sale of TPHS business
Gain on sale of navvis business
Loss on derivatives
(Gain) loss on derivatives
Unrealized gain on investments in equity securities
Realized gain on investments in equity securities
Impairment of goodwill and intangible assets of discontinued operation
Loss on sale of Nutrition business
MeYou Health
TPHS Business
Total loss on sale of Nutrition business

Loss on release of cumulative translation adjustment
Equity in income from joint ventures
Deferred income taxes
(Increase) decrease in accounts receivable, net
Decrease in inventory
Changes in income taxes receivable and payable
(Increase) decrease in other current assets
Decrease in accounts payable
Increase in accrued salaries and benefits
Increase (decrease) in other current liabilities
Other

Net cash flows provided by operating activities
Cash flows from investing activities:
Acquisition of property and equipment
Investment in joint ventures
Proceeds from sale of Nutrition business, net of cash transferred
Proceeds From sale of navvis
Payments related to sale of TPHS business
Other
Proceeds from sale of equity securities
Settlement on derivatives not designated as hedges
Business acquisitions, net of cash acquired
Net cash flows provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from issuance of long-term debt
Payments of long-term debt
Proceeds from settlement of cash convertible notes hedges
Payments related to settlement of cash conversion derivative
Deferred loan costs
Proceeds from non-controlling interest
Principal payments related to finance leases
Payments related to tax withholding for share-based compensation
Proceeds from exercise of stock options
Repurchases of common stock
Change in cash overdraft and other
Net cash flows provided by (used in) financing activities

Effect of exchange rate changes on cash
Less: net (decrease) increase in discontinued operations cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes, net of refunds
Issuance of CareFirst Warrants
Assets acquired through capital lease obligation
Conversion of CareFirst Convertible Note
Net working capital settlement expected from sale of Nutrisystem (see Note 2)

Comments